|
|
ANN ARBOR, Mich., Aug. 31 /PRNewswire-USNewswire/ — Compendia Bioscience, Inc. today announced the award of $1.3 million in SBIR Fast Track funds to incorporate micro-RNA data and analyses into the Oncomine platform.
Cancer is a highly complex disease in which all of the causes and effects are not well understood. In recent years a new type of non-coding RNA molecule — micro-RNA — has been identified as an important contributor to cancer development, progression, and
Continue reading: Compendia Bioscience Awarded $1.3 Million in SBIR Fast Track Funds
Ann Arbor, MI – August 24, 2010
Accuri Cytometers, Inc. and BioTech a.s. are pleased to announce the launch of the Accuri C6 Flow Cytometer system in Czech Republic, Slovak Republic and Hungary.
The two companies have signed an exclusive distribution agreement giving Czech, Slovak and Hungarian researchers access to Accuri’s products for the first time. BioTech a.s. is now responsible for the marketing, sales, support and technical service for Accuri Cytometers products in these countries.
Continue reading: Accuri Cytometers Announces Launch of Accuri C6 Flow Cytometer System in Czech Republic
Ann Arbor, MICH. – August 2, 2010 – HealthMedia, Inc., a Johnson & Johnson company and part of the Wellness & Prevention business, announced that Sanjay Gupta will assume leadership for the company beginning August 16. Gupta will be responsible for providing strategic direction and helping to drive continued growth for HealthMedia® Digital Health Coaching solutions for employers, health plans, and other organizations.
Gupta brings over 13 years of leadership experience with
Continue reading: HealthMedia, Inc. Appoints New Leader For Digital Health Coaching Business
ANN ARBOR, Mich., (August 3, 2010) – NanoBio Corporation announced today that it has been awarded a seventh U.S. patent covering its novel nanoemulsion technology. The new claims encompass methods of treating Herpes Simplex I infections, including herpes labialis (commonly referred to as cold sores), using NanoBio’s proprietary anti-infective nanoemulsion product candidates.
This new patent covers NanoBio’s NB-001, a novel topical therapy for the treatment of cold sores that has been licensed to GlaxoSmithKline plc (GSK)
Continue reading: NanoBio Awarded New Patent Covering its Nanoemulsion-based Anti-infective Product
Jean-Pierre Garnier appointed as non-executive director to the board
Toulouse, France and Ann Arbor, MI, USA July 26, 2010 – Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company specializing in the research and development of novel therapies based on the metabolism of HDL (the “good” cholesterol) to treat cardiovascular and other metabolic diseases, announced today it has raised €40 million in the first close of its series C financing. In this round €20 million came from the
Continue reading: Cerenis Therapeutics raises EUR 40 million in series C financing
WASHINGTON, D.C. – Altarum Institute President and CEO Lincoln Smith presented written testimony today for the House of Representatives Committee on Veterans’ Affairs, Subcommittee on Health hearing on the use of wireless technologies for treating mental health issues among veterans. Smith’s testimony detailed Altarum’s “Veterans Transition to Community” project currently underway at a pilot site in California.
“We are tremendously excited about the potential shown in this project, and appreciate the opportunity Chairman Michaud and Ranking
Continue reading: Altarum Research Offers House Committee on Veterans’ Affairs High Tech Solutions
|
|
Loading ...
Ann Arbor, MI